trans-4-(3-benzylsulfanyl-pyridine-4-carbonyl)-cyclohexanecarboxylic acid methyl ester | 1345045-66-0

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: trans-4-(3-benzylsulfanyl-pyridine-4-carbonyl)-cyclohexanecarboxylic acid methyl ester
• CAS: 1345045-66-0
• 化学式: C₂₁H₂₃NO₃S
• 分子量: 369.485
• InChiKey: LXZMJBWSVDWHRV-QAQDUYKDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.54
• 重原子数：
  26.0
• 可旋转键数：
  6.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  56.26
• 氢给体数：
  0.0
• 氢受体数：
  5.0

文献信息

• HETEROBIARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES
  申请人：Dolente Cosimo

  公开号：US20110263573A1

  公开（公告）日：2011-10-27

  The present invention relates to heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes of formula I wherein R 1 , R 2 and R 3 are as described herein. The compounds according to the invention act as V1a receptor modulators, and in particular as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea, male or female sexual dysfunction, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, anxiety, depressive disorders, obsessive compulsive disorder, autistic spectrum disorders, schizophrenia, and aggressive behavior.

  本发明涉及公式I的杂环联苯基环己基四氮杂苯并[ e ]吲哚，其中R1、R2和R3如本文所述。根据本发明的化合物作为V1a受体调节剂，特别是作为V1a受体拮抗剂，其制造、含有它们的药物组合物以及它们作为药物的用途。本发明的活性化合物在治疗作用上对外周和中枢的功能障碍，如痛经、男性或女性性功能障碍、高血压、慢性心力衰竭、抗利尿素的不适当分泌、肝硬化、肾病综合征、焦虑、抑郁症、强迫性障碍、自闭症谱系障碍、精神分裂症和攻击性行为等方面具有用途。
• [EN] HETEROBIARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES<br/>[FR] HÉTÉROBIARYL-CYCLOHEXYL-TÉTRAAZABENZO[E]AZULÈNES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011134877A1

  公开（公告）日：2011-11-03

  The present invention relates to heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes of formula (I), wherein R1, R2 and R3 are as described herein. The compounds according to the invention act as V1a receptor modulators, and in particular as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea, male or female sexual dysfunction, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, anxiety, depressive disorders, obsessive compulsive disorder, autistic spectrum disorders, schizophrenia, and aggressive behavior.

  本发明涉及公式(I)的杂环双芳基环己基四氮杂苯并[ｅ]吖啉类化合物，其中R1、R2和R3如本文所述。根据本发明的化合物作为V1a受体调节剂，特别是作为V1a受体拮抗剂，其制备方法、含有它们的药物组合物以及它们作为药物的用途。本发明的活性化合物在治疗经外性和中枢条件下具有作用，如痛经、男性或女性性功能障碍、高血压、慢性心力衰竭、抗利尿素的异常分泌、肝硬化、肾病综合征、焦虑、抑郁障碍、强迫性障碍、自闭症谱系障碍、精神分裂症和攻击性行为。
• US8481528B2
  申请人：——

  公开号：US8481528B2

  公开（公告）日：2013-07-09